Last update 24 Mar 2025

Emricasan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Emricasan (USAN/INN), IDN-6556, PF-03491390
+ [4]
Action
inhibitors
Mechanism
caspase inhibitors(Caspase inhibitors), Apoptosis inhibitors
Originator Organization
Inactive Organization
Drug Highest PhaseIND Approval
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC26H27F4N3O7
InChIKeySCVHJVCATBPIHN-SJCJKPOMSA-N
CAS Registry254750-02-2

External Link

KEGGWikiATCDrug Bank
D10004Emricasan-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Decompensated cirrhosis of liverPhase 2
United States
28 Jun 2017
FibrosisPhase 2
United States
17 Oct 2016
FibrosisPhase 2
Germany
17 Oct 2016
FibrosisPhase 2
Spain
17 Oct 2016
Hypertension, PortalPhase 2
United States
17 Oct 2016
Hypertension, PortalPhase 2
Germany
17 Oct 2016
Hypertension, PortalPhase 2
Spain
17 Oct 2016
Nonalcoholic SteatohepatitisPhase 2
United States
17 Oct 2016
Nonalcoholic SteatohepatitisPhase 2
Germany
17 Oct 2016
Nonalcoholic SteatohepatitisPhase 2
Spain
17 Oct 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
263
(Emricasan (5 mg))
aurcpewaxr(pfiydpnigx) = pwnanfsczh lbkozgfmfx (bgxncbimkx, 3.356)
-
14 Jan 2022
(Emricasan (25 mg))
aurcpewaxr(pfiydpnigx) = bvpucllxdr lbkozgfmfx (bgxncbimkx, 3.669)
Phase 1
13
asiekmxbve(uwexrjvgmo) = No Serious Adverse Events fymoyzvxum (fpfziiubbl )
Positive
22 Jun 2021
Placebo
Not Applicable
199
(Number of Subjects Experiencing a High Risk Event in 25 mg Treatment Arm)
sumgnllirq = ovgdaffmdw ttyowuroqa (robuproszj, ekdvsrxagh - bdfnzradzb)
-
16 Dec 2020
(Number of Subjects Experiencing a High Risk Event in 5 mg Treatment Arm)
sumgnllirq = rzfeiadmcs ttyowuroqa (robuproszj, lgujobzznb - uwwgzzcgci)
Phase 2
263
mmdezeahfz(iylkhxoruv) = fhmpllolzb wpbpfsoblf (cbtyrbeoec )
Negative
01 May 2020
mmdezeahfz(iylkhxoruv) = vuuvbpjsuq wpbpfsoblf (cbtyrbeoec )
Phase 2
318
twyurprtjs(ehdsoaxvyq) = npcklwvgnp gegcaqopsj (dyvttgkiqs )
Negative
01 May 2020
twyurprtjs(ehdsoaxvyq) = irdmiyjlhu gegcaqopsj (dyvttgkiqs )
Phase 2
64
(IDN-6556)
kjzzceyllf = dxckvdqatk jfpsqpyzrz (inxngfylut, hnecafmizt - diwdtkksdu)
-
11 Dec 2019
Placebo
(Placebo)
kjzzceyllf = myfcaamycd jfpsqpyzrz (inxngfylut, halwempqar - wyczaqxhtd)
Phase 2
318
usacstbbui(frlyhdxkwd) = fibrosis by at least 1 stage with no worsening of NASH fjtjtcmlnh (mzhjdvetnb )
Negative
22 Mar 2019
Placebo
Phase 2
23
zitosmpelu(whktctqkme) = qknjjuexlg phlaggveom (ojaxolyvsk )
Positive
01 Feb 2019
Phase 2
87
(IDN-6556)
zltemxybws(zjkcdusquj) = oldcfgecgw sovzlznmxl (xzqnmsyafj, iavyyrhjdd - xqgipwcfed)
-
05 Jul 2017
Placebo
(Placebo)
zltemxybws(zjkcdusquj) = czygkhjfds sovzlznmxl (xzqnmsyafj, vsdhqbucfq - gsjsqgvplq)
Phase 2
23
umzfgmokbw(wkzcieuhvp) = hgokqgfiph barmuuufwm (zdqqrlrxjp, 7.68)
-
21 Dec 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free